{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:58:59Z","timestamp":1793325539505,"version":"4.5.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Science and Technology","award":["SERB\/TAR\/2021\/000250"],"award-info":[{"award-number":["SERB\/TAR\/2021\/000250"]}]},{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","award":["P\/11\/2024-US C1\/1"],"award-info":[{"award-number":["P\/11\/2024-US C1\/1"]}],"id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12033-024-01251-1","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T05:02:44Z","timestamp":1724130164000},"page":"2997-3009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases"],"prefix":"10.1007","volume":"67","author":[{"given":"V.","family":"Nithyasree","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Magdalene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8915-3542","authenticated-orcid":false,"given":"P. K.","family":"Praveen Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Preethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Michael","family":"Gromiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"issue":"1","key":"1251_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"M Abdul Basith Khan","year":"2020","unstructured":"Abdul Basith Khan, M., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al Kaabi, J. (2020). Epidemiology of type 2 diabetes\u2014global burden of disease and forecasted trends. Journal of Epidemiology and Global Health, 10(1), 107\u2013111.","journal-title":"Journal of Epidemiology and Global Health"},{"issue":"8","key":"1251_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3748\/wjg.v28.i8.775","volume":"28","author":"D Garc\u00eda-Compe\u00e1n","year":"2022","unstructured":"Garc\u00eda-Compe\u00e1n, D., Orsi, E., Kumar, R., Gundling, F., Nishida, T., Villarreal-P\u00e9rez, J. Z., Del Cueto-Aguilera, A. N., Gonz\u00e1lez-Gonz\u00e1lez, J. A., & Pugliese, G. (2022). Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives. World Journal of Gastroenterology, 28(8), 775.","journal-title":"World Journal of Gastroenterology"},{"issue":"11","key":"1251_CR3","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.3390\/nu15112521","volume":"15","author":"V Manilla","year":"2023","unstructured":"Manilla, V., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023). Type 2 Diabetes mellitus and liver disease: Across the gut-liver axis from fibrosis to cancer. Nutrients, 15(11), 2521.","journal-title":"Nutrients"},{"issue":"4","key":"1251_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jhep.2014.05.024","volume":"61","author":"A Ambade","year":"2014","unstructured":"Ambade, A., Catalano, D., Lim, A., Kopoyan, A., Shaffer, S. A., & Mandrekar, P. (2014). Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury. Journal of Hepatology, 61(4), 903\u2013911. https:\/\/doi.org\/10.1016\/j.jhep.2014.05.024","journal-title":"Journal of Hepatology"},{"issue":"6","key":"1251_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.bjp.0706396","volume":"18","author":"FH Schopf","year":"2017","unstructured":"Schopf, F. H., Biebl, M. M., & Buchner, J. (2017). The HSP90 chaperone machinery. Nature Reviews Molecular Cell Biology, 18(6), 345\u2013360. https:\/\/doi.org\/10.1038\/sj.bjp.0706396","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"1251_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbrc.2022.07.033","volume":"622","author":"W Zhang","year":"2022","unstructured":"Zhang, W., Xue, H., Zhou, C., Zheng, Z., Xing, M., Chu, H., Ping, Li., Naixia, Z., Yongjun, D., & Xu, X. (2022). 7-aminocephalosporanic acid, a novel HSP90\u03b2 inhibitor, attenuates HFD-induced hepatic steatosis. Biochemical and Biophysical Research Communications, 622, 184\u2013191. https:\/\/doi.org\/10.1016\/j.bbrc.2022.07.033","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"1251_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/1573395513666170606121625","volume":"13","author":"C Habich","year":"2017","unstructured":"Habich, C., Sell, H., & Burkart, V. (2017). Regulatory role of heat shock proteins in the pathogenesis of type 1 and type 2 diabetes. Current Immunology Reviews, 13(1), 82\u201390.","journal-title":"Current Immunology Reviews"},{"issue":"3","key":"1251_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.161","volume":"3","author":"C Hu","year":"2022","unstructured":"Hu, C., Yang, J., Qi, Z., Wu, H., Wang, B., Zou, F., Mei, H., Liu, J., Wang, W., & Liu, Q. (2022). Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities. MedComm, 3(3), e161.","journal-title":"MedComm"},{"key":"1251_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-7-156","volume":"7","author":"B Chen","year":"2006","unstructured":"Chen, B., Zhong, D., & Monteiro, A. (2006). Comparative genomics and evolution of the HSP90 family of genes across all kingdoms of organisms. BMC Genomics, 7, 1\u201319.","journal-title":"BMC Genomics"},{"issue":"5","key":"1251_CR10","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/S0021-9258(19)81631-9","volume":"264","author":"SP Lees-Miller","year":"1989","unstructured":"Lees-Miller, S. P., & Anderson, C. W. (1989). Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved serines that are phosphorylated in vitro by casein kinase II. Journal of Biological Chemistry, 264(5), 2431\u20132437.","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"1251_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0163-7258(98)00013-8","volume":"79","author":"P Csermely","year":"1998","unstructured":"Csermely, P., Schnaider, T., So, C., Proh\u00e1szka, Z., & Nardai, G. (1998). The 90-kDa molecular chaperone family: Structure, function, and clinical applications. A comprehensive review. Pharmacology & Therapeutics, 79(2), 129\u2013168.","journal-title":"Pharmacology & Therapeutics"},{"issue":"3","key":"1251_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.bbamcr.2011.08.007","volume":"1823","author":"DC Altieri","year":"2012","unstructured":"Altieri, D. C., Stein, G. S., Lian, J. B., & Languino, L. R. (2012). TRAP-1, the mitochondrial HSP90. Biochimica et Biophysica Acta (BBA) \u2013 Molecular Cell Research, 1823(3), 767\u2013773.","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Molecular Cell Research"},{"key":"1251_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00580-019-02902-5","volume":"28","author":"KF Amawi","year":"2019","unstructured":"Amawi, K. F., Al-Mazari, I. S., Alsarhan, A., Alhamad, H. Q. M., & Alkhatib, A. J. (2019). Diabetes upregulates the expression of HSP90 and downregulates HSP70 in the liver of diabetic rats. Comparative Clinical Pathology, 28, 473\u2013478.","journal-title":"Comparative Clinical Pathology"},{"key":"1251_CR14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00109-014-1168-8","volume":"92","author":"DH Jo","year":"2014","unstructured":"Jo, D. H., An, H., Chang, D. J., Baek, Y. Y., Cho, C. S., Jun, H. O., Park, S. J., Kim, J. H., Lee, H. Y., Kim, K. W., & Lee, J. (2014). Hypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina is suppressed by HIF-1\u03b1 destabilization by SH-1242 and SH-1280, novel hsp90 inhibitors. Journal of Molecular Medicine, 92, 1083\u20131092.","journal-title":"Journal of Molecular Medicine"},{"issue":"12","key":"1251_CR15","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3390\/ijms18122709","volume":"18","author":"S Bellini","year":"2017","unstructured":"Bellini, S., Barutta, F., Mastrocola, R., Imperatore, L., Bruno, G., & Gruden, G. (2017). Heat shock proteins in vascular diabetic complications: Review and future perspective. International Journal of Molecular Sciences, 18(12), 2709.","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"1251_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.bbrc.2012.12.029","volume":"430","author":"JH Lee","year":"2013","unstructured":"Lee, J. H., Gao, J., Kosinski, P. A., Elliman, S. J., Hughes, T. E., Gromada, J., & Kemp, D. M. (2013). Heat shock protein 90 (HSP90) inhibitors activate the heat shock factor 1 (HSF1) stress response pathway and improve glucose regulation in diabetic mice. Biochemical and Biophysical Research Communications, 430(3), 1109\u20131113.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"1251_CR17","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1007\/s12272-015-0636-1","volume":"38","author":"YH Seo","year":"2015","unstructured":"Seo, Y. H. (2015). Organelle-specific HSP90 inhibitors. Archives of Pharmacal Research, 38, 1582\u20131590.","journal-title":"Archives of Pharmacal Research"},{"issue":"1","key":"1251_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","volume":"570","author":"AD Zuehlke","year":"2015","unstructured":"Zuehlke, A. D., Beebe, K., Neckers, L., & Prince, T. (2015). Regulation and function of the human HSP90AA1 gene. Gene, 570(1), 8\u201316.","journal-title":"Gene"},{"issue":"9","key":"1251_CR19","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/biom12091166","volume":"12","author":"S Maiti","year":"2022","unstructured":"Maiti, S., & Picard, D. (2022). Cytosolic HSP90 isoform-specific functions and clinical significance. Biomolecules, 12(9), 1166.","journal-title":"Biomolecules"},{"issue":"16","key":"1251_CR20","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1042\/BCJ20160005","volume":"473","author":"C Prodromou","year":"2016","unstructured":"Prodromou, C. (2016). Mechanisms of HSP90 regulation. Biochemical Journal, 473(16), 2439\u20132452.","journal-title":"Biochemical Journal"},{"issue":"1\u20133","key":"1251_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0014-5793(04)00229-7","volume":"562","author":"AS Sreedhar","year":"2004","unstructured":"Sreedhar, A. S., Kalm\u00e1r, \u00c9., Csermely, P., & Shen, Y. F. (2004). HSP90 isoforms: Functions, expression and clinical importance. FEBS Letters, 562(1\u20133), 11\u201315.","journal-title":"FEBS Letters"},{"issue":"12","key":"1251_CR22","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1016\/S0021-9258(18)83502-5","volume":"264","author":"SJ Ullrich","year":"1989","unstructured":"Ullrich, S. J., Moore, S. K., & Appella, E. (1989). Transcriptional and translational analysis of the murine 84-and 86-kDa heat shock proteins. Journal of Biological Chemistry, 264(12), 6810\u20136816.","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"1251_CR23","doi-asserted-by":"publisher","first-page":"014","DOI":"10.1186\/1753-6561-4-S2-O14","volume":"4","author":"Z Zhao","year":"2010","unstructured":"Zhao, Z., Cheng, C. F., Kim, R., Chen, M., Woodley, D. T., & Li, W. (2010). Targeting secreted heat shock protein-90alpha (HSP90\u03b1) to prevent breast cancer progression. BMC Proceedings, 4(2), 014.","journal-title":"BMC Proceedings"},{"issue":"11","key":"1251_CR24","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1021\/acs.jproteome.7b00247","volume":"16","author":"N Elzakra","year":"2017","unstructured":"Elzakra, N., Cui, L., Liu, T., Li, H., Huang, J., & Hu, S. (2017). Mass spectrometric analysis of SOX11-binding proteins in head and neck cancer cells demonstrates the interaction of SOX11 and HSP90\u03b1. Journal of Proteome Research, 16(11), 3961\u20133968.","journal-title":"Journal of Proteome Research"},{"key":"1251_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-6489-0","volume":"20","author":"W Wei","year":"2020","unstructured":"Wei, W., Liu, M., Ning, S., Wei, J., Zhong, J., Li, J., Cai, Z., & Zhang, L. (2020). Diagnostic value of plasma HSP90\u03b1 levels for detection of hepatocellular carcinoma. BMC Cancer, 20, 1\u20139.","journal-title":"BMC Cancer"},{"issue":"13","key":"1251_CR26","doi-asserted-by":"publisher","first-page":"9001","DOI":"10.1074\/jbc.M112.437897","volume":"288","author":"WS Chen","year":"2013","unstructured":"Chen, W. S., Chen, C. C., Chen, L. L., Lee, C. C., & Huang, T. S. (2013). Secreted heat shock protein 90\u03b1 (HSP90\u03b1) induces nuclear factor-\u03baB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion. Journal of Biological Chemistry, 288(13), 9001\u20139010.","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"1251_CR27","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1161\/01.RES.0000124979.46214.E3","volume":"94","author":"H Lei","year":"2004","unstructured":"Lei, H., Romeo, G., & Kazlauskas, A. (2004). Heat shock protein 90\u03b1\u2013dependent translocation of Annexin II to the surface of endothelial cells modulates plasmin activity in the diabetic rat aorta. Circulation Research, 94(7), 902\u2013909.","journal-title":"Circulation Research"},{"issue":"13","key":"1251_CR28","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.1074\/jbc.M608985200","volume":"282","author":"H Lei","year":"2007","unstructured":"Lei, H., Venkatakrishnan, A., Yu, S., & Kazlauskas, A. (2007). Protein kinase A-dependent translocation of HSP90\u03b1 impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. Journal of Biological Chemistry, 282(13), 9364\u20139371.","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"1251_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1006\/niox.2001.0394","volume":"6","author":"AJ Maxwell","year":"2002","unstructured":"Maxwell, A. J. (2002). Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide, 6(2), 101\u2013124.","journal-title":"Nitric Oxide"},{"issue":"8","key":"1251_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1161\/01.CIR.0000027109.14149.67","volume":"106","author":"KY Lin","year":"2002","unstructured":"Lin, K. Y., Ito, A., Asagami, T., Tsao, P. S., Adimoolam, S., Kimoto, M., Tsuji, H., Reaven, G. M., & Cooke, J. P. (2002). Impaired nitric oxide synthase pathway in diabetes mellitus: Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation, 106(8), 987\u2013992.","journal-title":"Circulation"},{"issue":"1","key":"1251_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002579","volume":"10","author":"X Ding","year":"2022","unstructured":"Ding, X., Meng, C., Dong, H., Zhang, S., Zhou, H., Tan, W., Huang, L., He, A., Li, J., Huang, J., & Li, W. (2022). Extracellular HSP90\u03b1, which participates in vascular inflammation, is a novel serum predictor of atherosclerosis in type 2 diabetes. BMJ Open Diabetes Research and Care, 10(1), e002579.","journal-title":"BMJ Open Diabetes Research and Care"},{"issue":"3","key":"1251_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.gpb.2021.07.004","volume":"19","author":"G Liu","year":"2021","unstructured":"Liu, G., Li, Y., Zhang, T., Li, M., Li, S., He, Q., Liu, S., Xu, M., Xiao, T., Shao, Z., & Shi, W. (2021). Single-cell RNA sequencing reveals sexually dimorphic transcriptome and type 2 diabetes genes in mouse islet \u03b2 cells. Genomics, Proteomics and Bioinformatics, 19(3), 408\u2013422.","journal-title":"Genomics, Proteomics and Bioinformatics"},{"issue":"4","key":"1251_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/his.12675","volume":"67","author":"SH Kim","year":"2015","unstructured":"Kim, S. H., Ji, J. H., Park, K. T., Lee, J. H., Kang, K. W., Park, J. H., Hwang, S. W., Lee, E. H., Cho, Y. J., Jeong, Y. Y., & Kim, H. C. (2015). High-level expression of HSP90\u03b2 is associated with poor survival in resectable non-small-cell lung cancer patients. Histopathology, 67(4), 509\u2013519.","journal-title":"Histopathology"},{"key":"1251_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-017-0640-9","volume":"16","author":"J Meng","year":"2017","unstructured":"Meng, J., Liu, Y., Han, J., Tan, Q., Chen, S., Qiao, K., Zhou, H., Sun, T., & Yang, C. (2017). HSP90\u03b2 promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma. Molecular Cancer, 16, 1\u201311.","journal-title":"Molecular Cancer"},{"issue":"2","key":"1251_CR35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3892\/or.2016.5295","volume":"37","author":"S Li","year":"2017","unstructured":"Li, S., Li, J., Hu, T., Zhang, C., Lv, X., He, S., Yan, H., Tan, Y., Wen, M., Lei, M., & Zuo, J. (2017). Bcl-2 overexpression contributes to laryngeal carcinoma cell survival by forming a complex with HSP90\u03b2. Oncology Reports, 37(2), 849\u2013856.","journal-title":"Oncology Reports"},{"issue":"2","key":"1251_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2021.152070","volume":"226","author":"AL Heck","year":"2021","unstructured":"Heck, A. L., Mishra, S., Prenzel, T., Feulner, L., Achhammer, E., Sarchen, V., Blagg, B. S. J., Schneider-Brachert, W., Schutze, S., & Fritsch, J. (2021). Selective HSP90\u03b2 inhibition results in TNF and TRAIL mediated HIF1\u03b1 degradation. Immunobiology, 226(2), 152070.","journal-title":"Immunobiology"},{"issue":"2","key":"1251_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrm2335","volume":"9","author":"MP Wymann","year":"2008","unstructured":"Wymann, M. P., & Schneiter, R. (2008). Lipid signalling in disease. Nature Reviews Molecular Cell Biology, 9(2), 162\u2013176.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"1","key":"1251_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000075925","volume":"24","author":"CK Abrass","year":"2004","unstructured":"Abrass, C. K. (2004). Cellular lipid metabolism and the role of lipids in progressive renal disease. American Journal of Nephrology, 24(1), 46\u201353. https:\/\/doi.org\/10.1159\/000075925","journal-title":"American Journal of Nephrology"},{"issue":"1","key":"1251_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5551\/jat.E607","volume":"16","author":"A Kawakami","year":"2009","unstructured":"Kawakami, A., & Yoshida, M. (2009). Apolipoprotein CIII links dyslipidemia with atherosclerosis. Journal of Atherosclerosis and Thrombosis, 16(1), 6\u201311.","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"issue":"3","key":"1251_CR40","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41418-022-01071-3","volume":"30","author":"HM Cheng","year":"2023","unstructured":"Cheng, H. M., Xing, M., Zhou, Y. P., Zhang, W., Liu, Z., Li, L., Zheng, Z., Ma, Y., Li, P., Liu, X., & Li, P. (2023). HSP90\u03b2 promotes osteoclastogenesis by dual-activation of cholesterol synthesis and NF-\u03baB signaling. Cell Death & Differentiation, 30(3), 673\u2013686.","journal-title":"Cell Death & Differentiation"},{"issue":"20","key":"1251_CR41","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.7150\/thno.36505","volume":"9","author":"ZG Zheng","year":"2019","unstructured":"Zheng, Z. G., Zhang, X., Liu, X. X., Jin, X. X., Dai, L., Cheng, H. M., Jing, D., Thu, P. M., Zhang, M., Li, H., & Zhu, J. (2019). Inhibition of HSP90\u03b2 improves lipid disorders by promoting mature SREBPs degradation via the ubiquitin-proteasome system. Theranostics, 9(20), 5769.","journal-title":"Theranostics"},{"key":"1251_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-018-0242-6","volume":"15","author":"E Jing","year":"2018","unstructured":"Jing, E., Sundararajan, P., Majumdar, I. D., Hazarika, S., Fowler, S., Szeto, A., Gesta, S., Mendez, A. J., Vishnudas, V. K., Sangarajan, R., & Narain, N. R. (2018). HSP90\u03b2 knockdown in DIO mice reverses insulin resistance and improves glucose tolerance. Nutrition & Metabolism, 15, 1\u201310.","journal-title":"Nutrition & Metabolism"},{"key":"1251_CR43","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1007\/s00018-012-1177-0","volume":"70","author":"DC Altieri","year":"2013","unstructured":"Altieri, D. C. (2013). HSP90 regulation of mitochondrial protein folding: From organelle integrity to cellular homeostasis. Cellular and Molecular Life Sciences, 70, 2463\u20132472.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"3","key":"1251_CR44","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jmb.2004.09.055","volume":"344","author":"SH McLaughlin","year":"2004","unstructured":"McLaughlin, S. H., Ventouras, L. A., Lobbezoo, B., & Jackson, S. E. (2004). Independent ATPase activity of HSP90 subunits creates a flexible assembly platform. Journal of Molecular Biology, 344(3), 813\u2013826.","journal-title":"Journal of Molecular Biology"},{"issue":"5","key":"1251_CR45","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1074\/jbc.275.5.3305","volume":"275","author":"SJ Felts","year":"2000","unstructured":"Felts, S. J., Owen, B. A., Nguyen, P., Trepel, J., Donner, D. B., & Toft, D. O. (2000). The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. Journal of Biological Chemistry, 275(5), 3305\u20133312.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"1251_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2353\/ajpath.2010.090521","volume":"176","author":"I Leav","year":"2010","unstructured":"Leav, I., Plescia, J., Goel, H. L., Li, J., Jiang, Z., Cohen, R. J., Languino, L. R., & Altieri, D. C. (2010). Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. The American Journal of Pathology, 176(1), 393\u2013401.","journal-title":"The American Journal of Pathology"},{"issue":"1","key":"1251_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2009.01.018","volume":"279","author":"E Costantino","year":"2009","unstructured":"Costantino, E., Maddalena, F., Calise, S., Piscazzi, A., Tirino, V., Fersini, A., Ambrosi, A., Neri, V., Esposito, F., & Landriscina, M. (2009). TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells. Cancer letters, 279(1), 39\u201346.","journal-title":"Cancer letters"},{"issue":"16","key":"1251_CR48","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.1158\/0008-5472.CAN-10-1256","volume":"70","author":"M Landriscina","year":"2010","unstructured":"Landriscina, M., Laudiero, G., Maddalena, F., Amoroso, M. R., Piscazzi, A., Cozzolino, F., Monti, M., Garbi, C., Fersini, A., Pucci, P., & Esposito, F. (2010). Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents. Cancer Research, 70(16), 6577\u20136586.","journal-title":"Cancer Research"},{"issue":"1","key":"1251_CR49","first-page":"6431517","volume":"2020","author":"L Liu","year":"2020","unstructured":"Liu, L., Zhang, L., Zhao, J., Guo, X., Luo, Y., Hu, W., & Zhao, T. (2020). Tumor necrosis factor receptor-associated protein 1 protects against mitochondrial injury by preventing high glucose-induced mPTP opening in diabetes. Oxidative Medicine and Cellular Longevity, 2020(1), 6431517.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"8","key":"1251_CR50","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3390\/cells9081844","volume":"9","author":"Y Argon","year":"2020","unstructured":"Argon, Y., Bresson, S. E., Marzec, M. T., & Grimberg, A. (2020). Glucose-regulated protein 94 (GRP94): A novel regulator of insulin-like growth factor production. Cells, 9(8), 1844.","journal-title":"Cells"},{"issue":"3","key":"1251_CR51","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.bbamcr.2011.10.013","volume":"1823","author":"M Marzec","year":"2012","unstructured":"Marzec, M., Eletto, D., & Argon, Y. (2012). GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum. Biochimica et Biophysica Acta (BBA) \u2013 Molecular Cell Research, 1823(3), 774\u2013787.","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Molecular Cell Research"},{"issue":"5","key":"1251_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010852","volume":"5","author":"C Mao","year":"2010","unstructured":"Mao, C., Wang, M., Luo, B., Wey, S., Dong, D., Wesselschmidt, R., Rawlings, S., & Lee, A. S. (2010). Targeted mutation of the mouse Grp94 gene disrupts development and perturbs endoplasmic reticulum stress signaling. PLoS ONE, 5(5), e10852.","journal-title":"PLoS ONE"},{"issue":"10","key":"1251_CR53","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1091\/mbc.e07-03-0275","volume":"18","author":"S Wanderling","year":"2007","unstructured":"Wanderling, S., Simen, B. B., Ostrovsky, O., Ahmed, N. T., Vogen, S. M., Gidalevitz, T., & Argon, Y. (2007). GRP94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion. Molecular Biology of the Cell, 18(10), 3764\u20133775.","journal-title":"Molecular Biology of the Cell"},{"issue":"12","key":"1251_CR54","first-page":"2380","volume":"115","author":"M Staron","year":"2010","unstructured":"Staron, M., Yang, Y., Liu, B., Li, J., Shen, Y., Z\u00fa\u00f1iga-Pfl\u00fccker, J. C., Aguila, H. L., Goldschneider, I., & Li, Z. (2010). gp96, an endoplasmic reticulum master chaperone for integrins and Toll-like receptors, selectively regulates early T and B lymphopoiesis. Blood, The Journal of the American Society of Hematology, 115(12), 2380\u20132390.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"2","key":"1251_CR55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.immuni.2006.12.005","volume":"26","author":"Y Yang","year":"2007","unstructured":"Yang, Y., Liu, B., Dai, J., Srivastava, P. K., Zammit, D. J., Lefran\u00e7ois, L., & Li, Z. (2007). Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity, 26(2), 215\u2013226.","journal-title":"Immunity"},{"issue":"4","key":"1251_CR56","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2337\/db18-0671","volume":"68","author":"SM Ghiasi","year":"2019","unstructured":"Ghiasi, S. M., Dahlby, T., Hede Andersen, C., Haataja, L., Petersen, S., Omar-Hmeadi, M., Yang, M., Pihl, C., Bresson, S. E., Khilji, M. S., Klindt, K., Cheta, O., Perone, M. J., Tyrberg, B., Prats, C., Barg, S., Tengholm, A., Arvan, P., Mandrup-Poulsen, T., & Marzec, M. T. (2019). Endoplasmic reticulum chaperone glucose-regulated protein 94 is essential for proinsulin handling. Diabetes, 68(4), 747\u2013760.","journal-title":"Diabetes"},{"issue":"6","key":"1251_CR57","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/sj.bjp.0706396","volume":"146","author":"C Soti","year":"2005","unstructured":"Soti, C., Nagy, E., Giricz, Z., V\u00edgh, L., Csermely, P., & Ferdinandy, P. (2005). Heat shock proteins as emerging therapeutic targets. British Journal of Pharmacology, 146(6), 769\u2013780.","journal-title":"British Journal of Pharmacology"},{"key":"1251_CR58","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbrc.2022.07.033","volume":"622","author":"W Zhang","year":"2022","unstructured":"Zhang, W., Xue, H., Zhou, C., Zheng, Z., Xing, M., Chu, H., Li, P., Zhang, N., Dang, Y., & Xu, X. (2022). 7-aminocephalosporanic acid, a novel HSP90\u03b2 inhibitor, attenuates HFD-induced hepatic steatosis. Biochemical and Biophysical Research Communications, 622, 184\u2013191.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"1251_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.639596","volume":"9","author":"H Liu","year":"2021","unstructured":"Liu, H., Zhang, Z., Huang, Y., Wei, W., Ning, S., Li, J., Liang, X., Liu, K., & Zhang, L. (2021). Plasma HSP90AA1 predicts the risk of breast cancer onset and distant metastasis. Frontiers in Cell and Developmental Biology, 9, 639596. https:\/\/doi.org\/10.3389\/fcell.2021.639596","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"12","key":"1251_CR60","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1002\/jcp.29776","volume":"235","author":"M Nouri-Vaskeh","year":"2020","unstructured":"Nouri-Vaskeh, M., Alizadeh, L., Hajiasgharzadeh, K., Mokhtarzadeh, A., Halimi, M., & Baradaran, B. (2020). The role of HSP90 molecular chaperones in hepatocellular carcinoma. Journal of Cellular Physiology, 235(12), 9110\u20139120. https:\/\/doi.org\/10.1002\/jcp.29776","journal-title":"Journal of Cellular Physiology"},{"issue":"3","key":"1251_CR61","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.bbamcr.2011.09.009","volume":"1823","author":"W Li","year":"2012","unstructured":"Li, W., Sahu, D., & Tsen, F. (2012). Secreted heat shock protein-90 (HSP90) in wound healing and cancer. Biochimica et Biophysica Acta (BBA) \u2013 Molecular Cell Research, 1823(3), 730\u2013741.","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Molecular Cell Research"},{"key":"1251_CR62","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.2147\/OTT.S159432","volume":"11","author":"X Xiang","year":"2018","unstructured":"Xiang, X., You, X. M., & Li, L. Q. (2018). Expression of HSP90AA1\/HSPA8 in hepatocellular carcinoma patients with depression. OncoTargets and Therapy, 11, 3013\u20133023.","journal-title":"OncoTargets and Therapy"},{"issue":"2","key":"1251_CR63","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4236\/ijcm.2020.112005","volume":"11","author":"Q Jiang","year":"2020","unstructured":"Jiang, Q., & Shen, X. (2020). Research progress of heat shock protein 90 and hepatocellular carcinoma. International Journal of Clinical Medicine, 11(2), 43\u201352.","journal-title":"International Journal of Clinical Medicine"},{"issue":"6","key":"1251_CR64","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/acer.14338","volume":"44","author":"A Choudhury","year":"2020","unstructured":"Choudhury, A., Bullock, D., Lim, A., Argemi, J., Orning, P., Lien, E., Bataller, R., & Mandrekar, P. (2020). Inhibition of HSP90 and activation of HSF1 diminish macrophage NLRP3 inflammasome activity in alcohol-associated liver injury. Alcoholism: Clinical and Experimental Research, 44(6), 1300\u20131311. https:\/\/doi.org\/10.1111\/acer.14338","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"12","key":"1251_CR65","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He, Y., Hara, H., & N\u00fa\u00f1ez, G. (2016). Mechanism and regulation of NLRP3 inflammasome activation. Trends in Biochemical Sciences, 41(12), 1012\u20131021.","journal-title":"Trends in Biochemical Sciences"},{"key":"1251_CR66","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ebiom.2017.09.007","volume":"24","author":"Y Fu","year":"2017","unstructured":"Fu, Y., Xu, X., Huang, D., Cui, D., Liu, L., Liu, J., He, Z., Liu, J., Zheng, S., & Luo, Y. (2017). Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: An official, large-scale, and multicenter clinical trial. eBioMedicine, 24, 56\u201363.","journal-title":"eBioMedicine"},{"issue":"5","key":"1251_CR67","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","volume":"29","author":"F Diraison","year":"2003","unstructured":"Diraison, F., Moulin, P. H., & Beylot, M. (2003). Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes & Metabolism, 29(5), 478\u2013485.","journal-title":"Diabetes & Metabolism"},{"issue":"1","key":"1251_CR68","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3892\/mmr.2018.9667","volume":"19","author":"L Dong","year":"2019","unstructured":"Dong, L., Xue, L., Zhang, C., Li, H., Cai, Z., & Guo, R. (2019). HSP90 interacts with HMGCR and promotes the progression of hepatocellular carcinoma. Molecular Medicine Reports, 19(1), 524\u2013532. https:\/\/doi.org\/10.3892\/mmr.2018.9667","journal-title":"Molecular Medicine Reports"},{"issue":"5","key":"1251_CR69","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tibs.2013.02.003","volume":"38","author":"A R\u00f6hl","year":"2013","unstructured":"R\u00f6hl, A., Rohrberg, J., & Buchner, J. (2013). The chaperone HSP90: Changing partners for demanding clients. Trends in Biochemical Sciences, 38(5), 253\u2013262.","journal-title":"Trends in Biochemical Sciences"},{"issue":"10","key":"1251_CR70","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/ijc","volume":"144","author":"G Augello","year":"2019","unstructured":"Augello, G., Emma, M. R., Cusimano, A., Azzolina, A., Mongiov\u00ec, S., Puleio, R., Cassata, G., Gulino, A., Belmonte, B., Gramignoli, R., & Strom, S. C. (2019). Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma. International Journal of Cancer, 144(10), 2613\u20132624. https:\/\/doi.org\/10.1002\/ijc","journal-title":"International Journal of Cancer"},{"issue":"4","key":"1251_CR71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4051\/ibc.2013.5.4.0009","volume":"5","author":"CN Im","year":"2013","unstructured":"Im, C. N., Zheng, Y., Kim, S. H., Huang, T. Q., Cho, D. H., & Seo, J. S. (2013). The establishment of tumor necrosis factor receptor-associated protein1 (TRAP1) transgenic mice and severe fat accumulation in the liver of TRAP1 mice during liver regeneration. Interdisciplinary Bio Central, 5(4), 9\u20131.","journal-title":"Interdisciplinary Bio Central"},{"key":"1251_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-024-01151-4","author":"PK Praveen Kumar","year":"2024","unstructured":"Praveen Kumar, P. K., Sundar, H., Balakrishnan, K., Subramaniam, S., Ramachandran, H., Kevin, M., & Michael Gromiha, M. (2024). The role of HSP90 and TRAP1 targets on treatment in hepatocellular carcinoma. Molecular Biotechnology. https:\/\/doi.org\/10.1007\/s12033-024-01151-4","journal-title":"Molecular Biotechnology"},{"issue":"1","key":"1251_CR73","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/ijms23010460","volume":"23","author":"SA Dabravolski","year":"2021","unstructured":"Dabravolski, S. A., Nikiforov, N. G., Zhuravlev, A. D., Orekhov, N. A., Mikhaleva, L. M., & Orekhov, A. N. (2021). The role of altered mitochondrial metabolism in thyroid cancer development and mitochondria-targeted thyroid cancer treatment. International Journal of Molecular Sciences, 23(1), 460.","journal-title":"International Journal of Molecular Sciences"},{"key":"1251_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-019-0412-6","volume":"39","author":"L Dong","year":"2019","unstructured":"Dong, L., & Neuzil, J. (2019). Targeting mitochondria as an anticancer strategy. Cancer Communications, 39, 1\u20133.","journal-title":"Cancer Communications"},{"key":"1251_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.629846","volume":"11","author":"X Duan","year":"2021","unstructured":"Duan, X., Iwanowycz, S., Ngoi, S., Hill, M., Zhao, Q., & Liu, B. (2021). Molecular chaperone GRP94\/GP96 in cancers: Oncogenesis and therapeutic target. Frontiers in Oncology, 11, 629846. https:\/\/doi.org\/10.3389\/fonc.2021.629846","journal-title":"Frontiers in Oncology"},{"issue":"22","key":"1251_CR76","doi-asserted-by":"publisher","first-page":"14059","DOI":"10.3390\/ijms232214059","volume":"23","author":"X Wang","year":"2022","unstructured":"Wang, X., Xin, H., Zhang, C., Gu, X., & Hao, Y. (2022). GRP94 inhabits the immortalized porcine hepatic stellate cells apoptosis under endoplasmic reticulum stress through modulating the expression of IGF-1 and ubiquitin. International Journal of Molecular Sciences, 23(22), 14059. https:\/\/doi.org\/10.3390\/ijms232214059","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"1251_CR77","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/sj.cdd.4401840","volume":"13","author":"J Wu","year":"2006","unstructured":"Wu, J., & Kaufman, R. J. (2006). From acute ER stress to physiological roles of the unfolded protein response. Cell Death & Differentiation, 13(3), 374\u2013384.","journal-title":"Cell Death & Differentiation"},{"key":"1251_CR78","doi-asserted-by":"crossref","unstructured":"Maiers, J. L., & Malhi, H. (2019, May). Endoplasmic reticulum stress in metabolic liver diseases and hepatic fibrosis. In Seminars in liver disease (Vol. 39, No. 02, pp. 235\u2013248). Thieme Medical Publishers.","DOI":"10.1055\/s-0039-1681032"},{"issue":"12","key":"1251_CR79","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/biomedicines8120571","volume":"8","author":"T Behl","year":"2020","unstructured":"Behl, T., Sharma, A., Sharma, L., Sehgal, A., Zengin, G., Brata, R., Fretila, O., & Bungau, S. (2020). Exploring the multifaceted therapeutic potential of withaferin A and its derivatives. Biomedicines, 8(12), 571.","journal-title":"Biomedicines"},{"key":"1251_CR80","doi-asserted-by":"publisher","first-page":"1135952","DOI":"10.3389\/fphar.2023.1135952","volume":"14","author":"VD Shiragannavar","year":"2023","unstructured":"Shiragannavar, V. D., Sannappa Gowda, N. G., Puttahanumantharayappa, L. D., Karunakara, S. H., Bhat, S., Prasad, S. K., Kumar, D. P., & Santhekadur, P. K. (2023). The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR\/FXR dual receptor activator. Frontiers in Pharmacology, 14, 1135952.","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"1251_CR81","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4331\/wjbc.v8.i2.120","volume":"8","author":"L Pirola","year":"2017","unstructured":"Pirola, L., & Ferraz, J. C. (2017). Role of pro-and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity. World Journal of Biological Chemistry, 8(2), 120.","journal-title":"World Journal of Biological Chemistry"},{"issue":"9","key":"1251_CR82","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nm.4145","volume":"22","author":"J Lee","year":"2016","unstructured":"Lee, J., Liu, J., Feng, X., Salazar Hern\u00e1ndez, M. A., Mucka, P., Ibi, D., Choi, J. W., & Ozcan, U. (2016). Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice. Nature Medicine, 22(9), 1023\u20131032.","journal-title":"Nature Medicine"},{"key":"1251_CR83","doi-asserted-by":"publisher","first-page":"1084757","DOI":"10.3389\/fphar.2023.1084757","volume":"14","author":"HH Alanazi","year":"2023","unstructured":"Alanazi, H. H., & Elfaki, E. (2023). The immunomodulatory role of Withania somnifera (L.) dunal in inflammatory diseases. Frontiers in Pharmacology, 14, 1084757.","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"1251_CR84","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bcp.2009.09.017","volume":"79","author":"Y Yu","year":"2010","unstructured":"Yu, Y., Hamza, A., Zhang, T., Gu, M., Zou, P., Newman, B., Li, Y., Gunatilaka, A. L., Zhang, C. G., & Sun, D. (2010). Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochemical pharmacology, 79(4), 542\u2013551.","journal-title":"Biochemical pharmacology"},{"key":"1251_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106260","volume":"181","author":"HY Liew","year":"2022","unstructured":"Liew, H. Y., Tan, X. Y., Chan, H. H., Khaw, K. Y., & Ong, Y. S. (2022). Natural HSP90 inhibitors as a potential therapeutic intervention in treating cancers: A comprehensive review. Pharmacological Research, 181, 106260.","journal-title":"Pharmacological Research"},{"issue":"1","key":"1251_CR86","doi-asserted-by":"publisher","first-page":"17625","DOI":"10.1038\/s41598-023-44904-y","volume":"13","author":"K Baghel","year":"2023","unstructured":"Baghel, K., Azam, Z., Srivastava, R., Gupta, N., & Kango, N. (2023). Withaferin-A attenuates diabetes mellitus induced male reproductive dysfunction mediated by ER\u03b1 in brain and testes of Swiss albino mice. Scientific Reports, 13(1), 17625.","journal-title":"Scientific Reports"},{"issue":"6","key":"1251_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218792","volume":"14","author":"M Khalilpourfarshbafi","year":"2019","unstructured":"Khalilpourfarshbafi, M., Devi Murugan, D., Abdul Sattar, M. Z., Sucedaram, Y., & Abdullah, N. A. (2019). Withaferin A inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice. PLoS ONE, 14(6), e0218792.","journal-title":"PLoS ONE"},{"issue":"4","key":"1251_CR88","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1039\/c0np00045k","volume":"28","author":"LX Chen","year":"2011","unstructured":"Chen, L. X., He, H., & Qiu, F. (2011). Natural withanolides: An overview. Natural Product Reports, 28(4), 705\u2013740.","journal-title":"Natural Product Reports"},{"key":"1251_CR89","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-3-319-41334-1_14","volume":"928","author":"PT White","year":"2016","unstructured":"White, P. T., Subramanian, C., Motiwala, H. F., & Cohen, M. S. (2016). Natural withanolides in the treatment of chronic diseases. Advances in Experimental Medicine and Biology, 928, 329\u2013373.","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"1251_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-021-00547-2","volume":"18","author":"H Ram","year":"2021","unstructured":"Ram, H., Kumar, P., Purohit, A., Kashyap, P., Kumar, S., Kumar, S., Singh, G., Alqarawi, A. A., Hashem, A., Abd-Allah, E. F., & Al-Arjani, A. B. F. (2021). Improvements in HOMA indices and pancreatic endocrinal tissues in type 2-diabetic rats by DPP-4 inhibition and antioxidant potential of an ethanol fruit extract of Withania coagulans. Nutrition & Metabolism, 18, 1\u201317.","journal-title":"Nutrition & Metabolism"},{"issue":"11","key":"1251_CR91","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/antiox9111107","volume":"9","author":"E Logie","year":"2020","unstructured":"Logie, E., & Vanden Berghe, W. (2020). Tackling chronic inflammation with withanolide phytochemicals\u2014a withaferin a perspective. Antioxidants, 9(11), 1107.","journal-title":"Antioxidants"},{"key":"1251_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.628506","volume":"10","author":"VD Shiragannavar","year":"2021","unstructured":"Shiragannavar, V. D., Gowda, N. G. S., Kumar, D. P., Mirshahi, F., & Santhekadur, P. K. (2021). Withaferin A acts as a novel regulator of liver X receptor-\u03b1 in HCC. Frontiers in Oncology, 10, 628506.","journal-title":"Frontiers in Oncology"},{"key":"1251_CR93","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.33263\/BRIAC111.81418155","volume":"11","author":"H Ram","year":"2020","unstructured":"Ram, H., & Singh, A. K. (2020). Improvements in insulin resistance and \u03b2-cells dysfunction by ddp-4 inhibition potential of Withania Somnifera (L.) dunal root extract in type 2 diabetic rat. Biointerface Research in Applied Chemistry, 11, 8141\u20138155.","journal-title":"Biointerface Research in Applied Chemistry"},{"issue":"11","key":"1251_CR94","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3109\/13880209.2016.1157193","volume":"54","author":"ST Devkar","year":"2016","unstructured":"Devkar, S. T., Kandhare, A. D., Zanwar, A. A., Jagtap, S. D., Katyare, S. S., Bodhankar, S. L., & Hegde, M. V. (2016). Hepatoprotective effect of withanolide-rich fraction in acetaminophen-intoxicated rat: Decisive role of TNF-\u03b1, IL-1\u03b2, COX-II and iNOS. Pharmaceutical Biology, 54(11), 2394\u20132403.","journal-title":"Pharmaceutical Biology"},{"issue":"13","key":"1251_CR95","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.3390\/molecules26133797","volume":"26","author":"M Olech","year":"2021","unstructured":"Olech, M., Ziemich\u00f3d, W., & Nowacka-Jechalke, N. (2021). The occurrence and biological activity of tormentic acid\u2014a review. Molecules, 26(13), 3797.","journal-title":"Molecules"},{"issue":"3","key":"1251_CR96","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.foodchem.2011.01.114","volume":"127","author":"CT Chang","year":"2011","unstructured":"Chang, C. T., Huang, S. S., Lin, S. S., Amagaya, S., Ho, H. Y., Hou, W. C., Shie, P.-H., Wu, J.-B., & Huang, G. J. (2011). Anti-inflammatory activities of tormentic acid from suspension cells of Eriobotrya japonica ex vivo and in vivo. Food Chemistry, 127(3), 1131\u20131137.","journal-title":"Food Chemistry"},{"issue":"04","key":"1251_CR97","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1055\/s-2006-962433","volume":"54","author":"MD Ivorra","year":"1988","unstructured":"Ivorra, M. D., Paya, M., & Villar, A. (1988). Hypoglycemic and insulin release effects of tormentic acid: A new hypoglycemic natural product. Planta Medica, 54(04), 282\u2013286.","journal-title":"Planta Medica"},{"issue":"5","key":"1251_CR98","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.3390\/ijms23052756","volume":"23","author":"M Ivanov","year":"2022","unstructured":"Ivanov, M., \u0106iri\u0107, A., & Stojkovi\u0107, D. (2022). Emerging antifungal targets and strategies. International Journal of Molecular Sciences, 23(5), 2756.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"1251_CR99","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/ddr.20340","volume":"71","author":"J Yang","year":"2010","unstructured":"Yang, J., Chen, H., Zhang, L., Wang, Q., & Lai, M. X. (2010). Anti-diabetic effect of standardized extract of Potentilla discolor Bunge and identification of its active components. Drug Development Research, 71(2), 127\u2013132.","journal-title":"Drug Development Research"},{"issue":"46","key":"1251_CR100","doi-asserted-by":"publisher","first-page":"10140","DOI":"10.1021\/acs.jafc.5b04400","volume":"63","author":"YH Kuo","year":"2015","unstructured":"Kuo, Y. H., Lin, C. H., & Shih, C. C. (2015). Antidiabetic and antihyperlipidemic properties of a triterpenoid compound, dehydroeburicoic acid, from Antrodia camphorata in vitro and in streptozotocin-induced mice. Journal of Agricultural and Food Chemistry, 63(46), 10140\u201310151.","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"1251_CR101","doi-asserted-by":"publisher","first-page":"1043527","DOI":"10.3389\/fphar.2022.1043527","volume":"13","author":"Q Song","year":"2022","unstructured":"Song, Q., Cheng, S. W., Li, D., Cheng, H., Lai, Y. S., Han, Q., Wu, H. Y., Shaw, P. C., & Zuo, Z. (2022). Gut microbiota mediated hypoglycemic effect of Astragalus membranaceus polysaccharides in db\/db mice. Frontiers in Pharmacology, 13, 1043527.","journal-title":"Frontiers in Pharmacology"},{"key":"1251_CR102","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.fct.2017.12.020","volume":"111","author":"M Kondeva-Burdina","year":"2018","unstructured":"Kondeva-Burdina, M., Shkondrov, A., Simeonova, R., Vitcheva, V., Krasteva, I., & Ionkova, I. (2018). In vitro\/in vivo antioxidant and hepatoprotective potential of defatted extract and flavonoids isolated from Astragalus spruneri Boiss. (Fabaceae). Food and Chemical Toxicology, 111, 631\u2013640.","journal-title":"Food and Chemical Toxicology"},{"key":"1251_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112690","volume":"148","author":"W Yingrui","year":"2022","unstructured":"Yingrui, W., Zheng, L., Guoyan, L., & Hongjie, W. (2022). Research progress of active ingredients of Scutellaria baicalensis in the treatment of type 2 diabetes and its complications. Biomedicine & Pharmacotherapy, 148, 112690.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"6","key":"1251_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.12076","volume":"23","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y., Su, Y., Zhang, J., Zhang, Y., Li, Y., Han, Y., Dong, X., Li, W., & Li, W. (2021). Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK\/mTOR-mediated autophagy. Molecular Medicine Reports, 23(6), 1\u201312.","journal-title":"Molecular Medicine Reports"},{"issue":"2","key":"1251_CR105","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/2225-4110.110415","volume":"3","author":"ZY Su","year":"2013","unstructured":"Su, Z. Y., Sun Hwang, L., Chiang, B. H., & Sheen, L. Y. (2013). Antihepatoma and liver protective potentials of Ganoderma lucidum (lingzhi) fermented in a medium containing black soybean and Astragalus membranaceus. Journal of Traditional and Complementary Medicine, 3(2), 110\u2013118.","journal-title":"Journal of Traditional and Complementary Medicine"},{"issue":"14","key":"1251_CR106","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.18632\/aging.204189","volume":"14","author":"JL Tang","year":"2022","unstructured":"Tang, J. L., Xin, M., & Zhang, L. C. (2022). Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury. Aging (Albany, NY), 14(14), 5855.","journal-title":"Aging (Albany, NY)"},{"issue":"10","key":"1251_CR107","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.3390\/cancers12102859","volume":"12","author":"C Kole","year":"2020","unstructured":"Kole, C., Charalampakis, N., Tsakatikas, S., Vailas, M., Moris, D., Gkotsis, E., Kykalos, S., Karamouzis, M. V., & Schizas, D. (2020). Immunotherapy for hepatocellular carcinoma: A 2021 update. Cancers, 12(10), 2859.","journal-title":"Cancers"},{"issue":"1","key":"1251_CR108","first-page":"8825387","volume":"2020","author":"D Yang","year":"2020","unstructured":"Yang, D., Wang, T., Long, M., & Li, P. (2020). Quercetin: Its main pharmacological activity and potential application in clinical medicine. Oxidative Medicine and Cellular Longevity, 2020(1), 8825387.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"12","key":"1251_CR109","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ptr.6486","volume":"33","author":"H Yang","year":"2019","unstructured":"Yang, H., Yang, T., Heng, C., Zhou, Y., Jiang, Z., Qian, X., Du, L., Mao, S., Yin, C., & Lu, Q. (2019). Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db\/db mice. Phytotherapy Research, 33(12), 3140\u20133152.","journal-title":"Phytotherapy Research"},{"issue":"3","key":"1251_CR110","doi-asserted-by":"publisher","first-page":"97","DOI":"10.24061\/2413-0737.XXVI.3.103.2022.16","volume":"26","author":"VP Prysyazhnyuk","year":"2022","unstructured":"Prysyazhnyuk, V. P., Senyuk, B. P., Glubochenko, O. V., Prysyazhnyuk, P. V., & Bukach, O. P. (2022). The role of quercetin in the treatment of liver diseases: The review based on experimental and clinical investigations. Bukovyna Medical Herald, 26(3), 97\u2013102.","journal-title":"Bukovyna Medical Herald"},{"issue":"4","key":"1251_CR111","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000363323","volume":"126","author":"S O\u2019Neill","year":"2014","unstructured":"O\u2019Neill, S., Harrison, E. M., Ross, J. A., Wigmore, S. J., & Hughes, J. (2014). Heat-shock proteins and acute ischaemic kidney injury. Nephron Experimental Nephrology, 126(4), 167\u2013174.","journal-title":"Nephron Experimental Nephrology"},{"issue":"7","key":"1251_CR112","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1007\/s11033-020-05641-x","volume":"47","author":"E K\u0131yga","year":"2020","unstructured":"K\u0131yga, E., \u015eengelen, A., Ad\u0131g\u00fczel, Z., & \u00d6nay U\u00e7ar, E. (2020). Investigation of the role of quercetin as a heat shock protein inhibitor on apoptosis in human breast cancer cells. Molecular Biology Reports, 47(7), 4957\u20134967.","journal-title":"Molecular Biology Reports"},{"key":"1251_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154703","volume":"113","author":"T Yang","year":"2023","unstructured":"Yang, T., Wang, Y., Cao, X., Peng, Y., Huang, J., Chen, L., Pang, J., Jiang, Z., Qian, S., Liu, Y., & Ying, C. (2023). Targeting mTOR\/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation. Phytomedicine, 113, 154703.","journal-title":"Phytomedicine"},{"issue":"8","key":"1251_CR114","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/life12081146","volume":"12","author":"P Ansari","year":"2022","unstructured":"Ansari, P., Choudhury, S. T., Seidel, V., Rahman, A. B., Aziz, M. A., Richi, A. E., Rahman, A., Jafrin, U. H., Hannan, J. M. A., & Abdel-Wahab, Y. H. (2022). Therapeutic potential of quercetin in the management of type-2 diabetes mellitus. Life, 12(8), 1146.","journal-title":"Life"},{"issue":"6","key":"1251_CR115","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/ph14060586","volume":"14","author":"AK Singh","year":"2021","unstructured":"Singh, A. K., Yadav, D., Sharma, N., & Jin, J. O. (2021). Dipeptidyl Peptidase (DPP)-IV inhibitors with antioxidant potential isolated from natural sources: A novel approach for the management of diabetes. Pharmaceuticals, 14(6), 586.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"1251_CR116","doi-asserted-by":"publisher","first-page":"94","DOI":"10.26502\/jfsnr.2642-11000065","volume":"4","author":"A Waslyk","year":"2021","unstructured":"Waslyk, A., & Bakovic, M. (2021). Biological activity and therapeutic potential of quercetin for inflammatory bowel disease. Journal of Food Science and Nutrition Research, 4(2), 94\u2013117.","journal-title":"Journal of Food Science and Nutrition Research"},{"issue":"10","key":"1251_CR117","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.bcp.2012.07.012","volume":"84","author":"VM Adhami","year":"2012","unstructured":"Adhami, V. M., Syed, D. N., Khan, N., & Mukhtar, H. (2012). Dietary flavonoid fisetin: A novel dual inhibitor of PI3K\/Akt and mTOR for prostate cancer management. Biochemical Pharmacology, 84(10), 1277\u20131281.","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"1251_CR118","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1159\/000493650","volume":"49","author":"CJ Liou","year":"2018","unstructured":"Liou, C. J., Wei, C. H., Chen, Y. L., Cheng, C. Y., Wang, C. L., & Huang, W. C. (2018). Fisetin protects against hepatic steatosis through regulation of the Sirt1\/AMPK and fatty acid \u03b2-oxidation signalling pathway in high-fat diet-induced obese mice. Cellular Physiology and Biochemistry, 49(5), 1870\u20131884.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"10","key":"1251_CR119","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/acer.13172","volume":"40","author":"Q Sun","year":"2016","unstructured":"Sun, Q., Zhang, W., Zhong, W., Sun, X., & Zhou, Z. (2016). Dietary fisetin supplementation protects against alcohol-induced liver injury in mice. Alcoholism: Clinical and Experimental Research, 40(10), 2076\u20132084.","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"1251_CR120","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00204-002-0346-6","volume":"76","author":"YC Chen","year":"2002","unstructured":"Chen, Y. C., Shen, S. C., Lee, W. R., Lin, H. Y., Ko, C. H., Shih, C. M., & Yang, L. L. (2002). Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Archives of Toxicology, 76, 351\u2013359.","journal-title":"Archives of Toxicology"},{"key":"1251_CR121","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765202320201408","volume":"95","author":"RA Ugan","year":"2023","unstructured":"Ugan, R. A., Cadirci, E., Un, H., Cinar, I., & Gurbuz, M. A. (2023). Fisetin attenuates paracetamol-induced hepatotoxicity by regulating CYP2E1 enzyme. Anais da Academia Brasileira de Ci\u00eancias, 95, e20201408.","journal-title":"Anais da Academia Brasileira de Ci\u00eancias"},{"issue":"8","key":"1251_CR122","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/antiox10081215","volume":"10","author":"IMN Molagoda","year":"2021","unstructured":"Molagoda, I. M. N., Athapaththu, A. M. G. K., Choi, Y. H., Park, C., Jin, C. Y., Kang, C. H., Lee, M.-H., & Kim, G. Y. (2021). Fisetin inhibits NLRP3 inflammasome by suppressing TLR4\/MD2-mediated mitochondrial ROS production. Antioxidants, 10(8), 1215.","journal-title":"Antioxidants"},{"issue":"S1","key":"1251_CR123","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.1002\/mc.22053","volume":"53","author":"MS Wu","year":"2014","unstructured":"Wu, M. S., Lien, G. S., Shen, S. C., Yang, L. Y., & Chen, Y. C. (2014). N-acetyl-L-cysteine enhances fisetin-induced cytotoxicity via induction of ROS-independent apoptosis in human colonic cancer cells. Molecular Carcinogenesis, 53(S1), E119\u2013E129.","journal-title":"Molecular Carcinogenesis"},{"key":"1251_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.808480","volume":"12","author":"D Li","year":"2022","unstructured":"Li, D., Liu, X., Pi, W., Zhang, Y., Yu, L., Xu, C., Sun, Z., & Jiang, J. (2022). Fisetin attenuates doxorubicin-induced cardiomyopathy in vivo and in vitro by inhibiting ferroptosis through SIRT1\/Nrf2 signaling pathway activation. Frontiers in Pharmacology, 12, 808480.","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"1251_CR125","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.arcmed.2020.10.009","volume":"52","author":"Z Li","year":"2021","unstructured":"Li, Z., Wang, Y., Zhang, Y., Wang, X., Gao, B., Li, Y., Li, R., & Wang, J. (2021). Protective effects of fisetin on hepatic ischemia-reperfusion injury through alleviation of apoptosis and oxidative stress. Archives of Medical Research, 52(2), 163\u2013173.","journal-title":"Archives of Medical Research"},{"issue":"6","key":"1251_CR126","doi-asserted-by":"publisher","first-page":"735","DOI":"10.4155\/fmc.11.18","volume":"3","author":"GL Wilson","year":"2011","unstructured":"Wilson, G. L., & Lill, M. A. (2011). Integrating structure-based and ligand-based approaches for computational drug design. Future Medicinal Chemistry, 3(6), 735\u2013750.","journal-title":"Future Medicinal Chemistry"},{"issue":"1","key":"1251_CR127","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/ijms24010339","volume":"24","author":"J Ye","year":"2022","unstructured":"Ye, J., Yang, X., & Ma, C. (2022). Ligand-Based Drug Design of Novel Antimicrobials against Staphylococcus aureus by Targeting Bacterial Transcription. International Journal of Molecular Sciences, 24(1), 339.","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"1251_CR128","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2174\/156802610791293118","volume":"10","author":"C Tintori","year":"2010","unstructured":"Tintori, C., Manetti, F., & Botta, M. (2010). Pharmacophoric models and 3D QSAR studies of the adenosine receptor ligands. Current Topics in Medicinal Chemistry, 10(10), 1019\u20131035.","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"1251_CR129","doi-asserted-by":"crossref","unstructured":"Sharma, V., Wakode, S., & Kumar, H. (2021). Structure-and ligand-based drug design: Concepts, approaches, and challenges. In Chemoinformatics and bioinformatics in the pharmaceutical sciences (pp. 27\u201353). Elsevier.","DOI":"10.1016\/B978-0-12-821748-1.00004-X"},{"issue":"17\u201318","key":"1251_CR130","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.drudis.2011.07.006","volume":"16","author":"S Kalyaanamoorthy","year":"2011","unstructured":"Kalyaanamoorthy, S., & Chen, Y. P. P. (2011). Structure-based drug design to augment hit discovery. Drug Discovery Today, 16(17\u201318), 831\u2013839.","journal-title":"Drug Discovery Today"},{"issue":"1","key":"1251_CR131","doi-asserted-by":"publisher","first-page":"2220558","DOI":"10.1080\/14756366.2023.2220558","volume":"38","author":"Y Xu","year":"2023","unstructured":"Xu, Y., Zou, Y., Zhou, S., Niu, M. M., Zhang, Y., Li, J., Xu, Z., & Yang, L. (2023). Discovery of potent heat shock protein 90 (HSP90) inhibitors: Structure-based virtual screening, molecular dynamics simulation, and biological evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry, 38(1), 2220558.","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"1251_CR132","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.sajb.2022.09.012","volume":"150","author":"W Chen","year":"2022","unstructured":"Chen, W., & Viljoen, A. M. (2022). Geraniol\u2013a review update. South African Journal of Botany, 150, 1205\u20131219.","journal-title":"South African Journal of Botany"},{"key":"1251_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2021.113058","volume":"195","author":"R Gaonkar","year":"2022","unstructured":"Gaonkar, R., Singh, J., Chauhan, A., Avti, P. K., & Hegde, G. (2022). Geraniol and citral as potential therapeutic agents targeting the HSP90 activity: An in silico and experimental approach. Phytochemistry, 195, 113058.","journal-title":"Phytochemistry"},{"issue":"1","key":"1251_CR134","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1080\/13880209.2017.1301494","volume":"55","author":"S Babukumar","year":"2017","unstructured":"Babukumar, S., Vinothkumar, V., Sankaranarayanan, C., & Srinivasan, S. (2017). Geraniol, a natural monoterpene, ameliorates hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Pharmaceutical Biology, 55(1), 1442\u20131449.","journal-title":"Pharmaceutical Biology"},{"key":"1251_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115467","volume":"210","author":"J Ma","year":"2023","unstructured":"Ma, J., Xu, Y., Zhang, M., & Li, Y. (2023). Geraniol ameliorates acute liver failure induced by lipopolysaccharide\/d-galactosamine via regulating macrophage polarization and NLRP3 inflammasome activation by PPAR-\u03b3 methylation geraniol alleviates acute liver failure. Biochemical Pharmacology, 210, 115467.","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"1251_CR136","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1158\/1535-7163.MCT-07-0484","volume":"7","author":"T Zhang","year":"2008","unstructured":"Zhang, T., Hamza, A., Cao, X., Wang, B., Yu, S., Zhan, C. G., & Sun, D. (2008). A novel HSP90 inhibitor to disrupt HSP90\/Cdc37 complex against pancreatic cancer cells. Molecular Cancer Therapeutics, 7(1), 162\u2013170.","journal-title":"Molecular Cancer Therapeutics"},{"issue":"2","key":"1251_CR137","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1021\/bi801637q","volume":"48","author":"Z Yin","year":"2009","unstructured":"Yin, Z., Henry, E. C., & Gasiewicz, T. A. (2009). (\u2212)-Epigallocatechin-3-gallate is a novel HSP90 inhibitor. Biochemistry, 48(2), 336\u2013345.","journal-title":"Biochemistry"},{"issue":"2","key":"1251_CR138","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1379\/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2","volume":"3","author":"TW Schulte","year":"1998","unstructured":"Schulte, T. W., Akinaga, S., Soga, S., Sullivan, W., Stensgard, B., Toft, D., & Neckers, L. M. (1998). Antibiotic radicicol binds to the N-terminal domain of HSP90 and shares important biologic activities with geldanamycin. Cell Stress & Chaperones, 3(2), 100.","journal-title":"Cell Stress & Chaperones"},{"key":"1251_CR139","first-page":"117955142311556","volume":"16","author":"V Alur","year":"2023","unstructured":"Alur, V., Raju, V., Vastrad, B., Vastrad, C., Kavatagimath, S., & Kotturshetti, S. (2023). Bioinformatics analysis of next generation sequencing data identifies molecular biomarkers associated with type 2 diabetes mellitus. Clinical Medicine Insights: Endocrinology and Diabetes, 16, 11795514231155636.","journal-title":"Clinical Medicine Insights: Endocrinology and Diabetes"},{"key":"1251_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104243","volume":"131","author":"AI Amanatidou","year":"2021","unstructured":"Amanatidou, A. I., & Dedoussis, G. V. (2021). Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease. Computers in Biology and Medicine, 131, 104243.","journal-title":"Computers in Biology and Medicine"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01251-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T01:10:34Z","timestamp":1757121034000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01251-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":140,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01251-1","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors claim no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}